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5a-dihydrotestosterone is known to play a crucial
part in the regulation of hair growth and in the
development of androgenetic alopecia. 5a-dihydro-
testosterone is formed locally within the hair follicle
from the systemic precursor testosterone by cuta-
neous steroid 5a-reductase. Moreover, adrenal ster-
oids such as dehydroepiandrosterone are converted
to 5a-dihydrotestosterone by isolated hair follicles,
which may provide an additional source of intrafolli-
cular 5a-dihydrotestosterone levels. Elevated urinary
dehydroepiandrosterone and serum dehydroepian-
drosterone sulfate have been reported to be present
in balding young men. These reports suggest that
dehydroepiandrosterone sulfate may act as an
important endocrine factor in the development of
androgenetic alopecia. Hence the question arises
whether the dehydroepiandrosterone sulfate can be
metabolized within the hair follicles to yield dehy-
droepiandrosterone by the microsomal enzyme ster-
oid sulfatase, and where steroid sulfatase might be
localized. We therefore performed immunostaining
for steroid sulfatase on human scalp biopsies as well
as analysis of steroid sulfatase enzyme activity in
de®ned compartments of human beard and occipital
hair follicles ex vivo. Using both methods steroid sul-
fatase was primarily detected in the dermal papilla.
Steroid sulfatase activity was inhibited by estrone-3-
O-sulfamate, a speci®c inhibitor of steroid sulfatase,
in a concentration-dependent way. Furthermore, we
show that dermal papillae are able to utilize dehy-
droepiandrosterone sulfate to produce 5a-dihydro-
testosterone, which lends further support to the
hypothesis that dehydroepiandrosterone sulfate con-
tributes to androgenetic alopecia and that steroid
sulfatase inhibitors could be novel drugs to
treat androgen-dependent disorders of the hair
follicle such as androgenetic alopecia or hirsutism.
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S
ince the early studies by Hamilton (1942, 1951) we know
that androgens play a crucial part in the onset and the
progression of androgenetic alopecia (AGA). He showed
that of 20 men with prepubertal gonadal insuf®ciency
none developed AGA, whereas of four castrated indivi-
duals treated with testosterone all developed the phenotype. Later it
became clear that among the different androgens 5a-dihydrotes-
tosterone (5a-DHT) is the principal pathogen for androgen-
sensitive hair follicles. The presence of type 2 steroid 5a-reductase
(5aR) in target organs is pivotal because of its function of
conversing testosterone into 5a-DHT. Individuals lacking this
enzyme do not develop AGA (Nowakowski and Lenz, 1961;
Imperato-McGinley et al, 1974, 1979; Andersson et al, 1991).
Abnormal serum concentrations of testosterone or 5a-DHT are not
a prerequisite for the development of AGA (Messenger, 1998). On
the contrary, the pathogenesis of AGA is driven within hair follicles
via an enhanced enzyme activity of steroid 5aR (Sawaya et al, 1988;
Itami et al, 1991; Randall et al, 1992). This process is triggered by
the type 2 5aR within the dermal papilla of 5a-DHT-sensitive hair
follicles (Eicheler et al, 1998; Hoffmann and Happle, 1999), and as
in other androgen target organs, such as the prostate, the extent of
the androgenic challenge is directly proportional to the concentra-
tion of 5a-DHT formed locally (Tenniswood et al, 1982). This local
production of 5a-DHT, however, depends on the concentration of
steroid precursors offered to the dermal papilla. Although
testosterone is the most important precursor for 5a-DHT, it has
been demonstrated that adrenal steroids, such as dehydroepian-
drosterone sulfate (DHEAS), can be converted to 5a-DHT by the
skin or by isolated pilosebaceous units, following the pathways
outlined in Fig 1 (Chakraborty et al, 1970; Faredin et al, 1970;
Voigt et al, 1982; Sawaya et al, 1988; Kaufman et al, 1990; Sawaya,
1991). Therefore, this potential pilosebaceous steroid metabolism
of the systemic precursors DHEA(S) might provide an additional
source of androgenic modulation to the hair follicle and thus may
promote or accelerate AGA.
DHEAS is the most abundant circulating steroid, with adult
plasma levels in the range of 0.5±10 mM (Orentreich et al, 1984).
Interestingly, Phillipou and Kirk (1981) reported an elevation of
urinary DHEA in balding young men, and Pitts (1987) observed
serum elevation of DHEAS (but not testosterone) associated with
balding in young men. Furthermore, in women with androgen-
dependent female-pattern alopecia, signi®cantly elevated DHEAS,
but normal testosterone serum levels, were observed (Kasick et al,
1983). This suggests that DHEAS may be an important endocrine
factor in the development of AGA. It has been shown that DHEAS
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can be cleaved within axillary hair follicles to yield directly 5a-
DHT to contribute to pilosebaceous 5a-DHT levels (Hay and
Hodgins, 1973), but the intrafollicular localization of this metabolic
process is unknown.
DHEAS is a substrate for the microsomal enzyme, steroid
sulfatase, which is present in almost all mammalian tissues (Martel et
al, 1994). In the context of the skin, steroid sulfatase has been
mainly studied as an epidermal enzyme responsible for cleavage of
cholesterol sulfate, whose genetic de®ciency is the cause of X-
linked recessive ichthyosis (Ballabio and Shapiro, 1995); however,
reports on the association of steroid sulfatase activity with the hair
follicle are con¯icting (Fazekas and Sandor, 1973; Meyer et al,
1979; Willems et al, 1986). Because of the potential importance of
steroid sulfatase during the development and progression of AGA,
we studied the localization of the steroid sulfatase protein in the
human hair follicle, as analyzed by immunohistochemistry, and the
steroid sulfatase enzyme activity in different subunits of the hair
follicle. In this study we demonstrate that steroid sulfatase is
predominantly expressed in the dermal papilla, that steroid sulfatase
is effectively inhibited by estrone sulfamate in this tissue, and that
the metabolic cascade induced by DHEAS leads to the production
of 5a-DHT within the dermal papilla of both occipital and beard
hair follicles.
MATERIALS AND METHODS
Chemicals and media Unlabeled DHEAS, DHEA, androstenedione,
androstenediol, and testosterone were bought from Sigma (Deisenhofen,
Germany). [1,2,6,7-3H(N)]-androst-4-ene-3,17-dione (speci®c activity:
74 Ci per mmol), [1,2,6,7-3H(N)]-androst-4-ene-3,17-diol (speci®c
activity: 74 Ci per mmol), [1,2,6,7-3H(N)]-DHEA (speci®c activity:
60 Ci per mmol), [1,2,4,5,6,7-3H(N)]-5a-dihydrotestosterone (5a-
androstane-17b-ol-3-one) (speci®c activity: 110 Ci per mmol),
[1,2,6,7-3H(N)]-DHEA-S (speci®c activity: 60 Ci per mmol),
[1,2,6,7-3H(N)]-testosterone (speci®c activity: 95 Ci per mmol) were
obtained from NEN Life Science (Boston, MA). Williams E medium
was purchased from BioWhittaker/Serva (Heidelberg, Germany) and L-
glutamine, insulin, transferrin, and sodium selenite from Sigma. The
steroid sulfatase-inhibitor estrone-3-O-sulfamate was synthesized at
Novartis Pharma following a published procedure (Howarth et al, 1994).
Figure 2. Subunits microdissected from hair follicles. (a) Complete hair follicle from a skin biopsy with dermal papilla, connective tissue sheath
and root sheath; (b) root sheath with inner and outer root sheath; (c) connective tissue sheath; (d) dermal papilla. Scale bars: (a±c) 500 mm; (d) 25 mm.
Figure 1. Pathways of androgen metabolism in the skin. This
scheme illustrates the possible pathways of different androgens in the
skin.
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Steroids and the inhibitor were added to the aqueous media from stock
solutions in ethanol.
Preparation of hair follicles and their subunits Informed consent
was obtained from 20 healthy volunteers (10 male, 10 female, age range
24±35 y, mean 28 y) and scalp biopsies were taken from the occiput
under local anesthesia. Furthermore, after informed consent skin pieces
containing beard hair follicles were obtained from four men (mean age
40 y) undergoing excision of basal cell carcinoma. The tissues were
collected from the margin of these excisions and did not contain nests of
basal cells carcinoma. Intact, viable anagen hair follicles were isolated by
microdissection as previously described (Eicheler et al, 1998). In brief,
scalp specimens were placed in Williams E medium supplemented with
L-glutamine (2 mM), insulin (10 mg per ml), transferrin 10 mg per ml),
and sodium selenite (10 ng per ml). Under a stereo-dissecting
microscope, a scalpel blade was used to remove the epidermis and upper
parts of the corium. Intact hair follicles were isolated carefully from the
subcutaneous fat with a watchmaker's forceps by gently gripping the
outer root sheath of the hair follicles and using subsequent slight traction.
Single hair follicles were either transferred to a 24-well culture dish and
incubated with [1,2,6,7-3H(N)]-DHEA-S, or they were further used to
microdissect the intact dermal papillae, connective tissue sheaths and root
sheath. For this purpose, the basal tip of the hair follicle was cut off just
above the visible dermal papilla, turned inside out, and the dermal papilla
was then cut off from its capillary stalk. The connective tissue sheaths
and root sheaths were separated by stripping the connective tissue sheaths
from the root sheath using gentle pressure by means of the blunt side of
a 26-gauge needle (Fig 2).
Morphologic characterization of subunits and volume
measurement of subunits by video imaging In order to determine
steroid enzyme activities, the volumes of the hair follicle subunits were
calculated for every dermal papilla, connective tissue sheath, and root
sheath immediately after microdissection and shortly before incubation
with different steroids. Digital images were taken at 3 10 or 3 40
magni®cation using an inverted microscope, a digital camera, and
original LUCIA M software version 2.995b (all: Nikon, DuÈsseldorf,
Germany). The software was calibrated with an objective micrometer
Figure 3. Conversion of [3H]-DHEAS to DHEA in complete hair
follicles Increasing numbers of intact anagen hair follicles were
incubated for 24 h in the presence of 5 mM DHEAS (with 2 mCi
[1,2,6,7-3H]-DHEAS) in a total volume of 400 ml. Culture supernatants
were analyzed by HPLC as described in Materials and Methods and
revealed the formation of DHEA as a reaction product. The amount of
DHEA formed was directly related to the number of hair follicles used
in the incubations.
Table I. Steroid sulfatase (pmol per h per mm3) activity is
predominantly expressed within the dermal papilla of
human hair follicles
Subunita
Occipital Beard
Mean SD Mean SD
DP 72.4 30.6 37.4 19.6
CTS 12.3 5.0 24.7 7.7
RS 9.05 1.8 15.7 3.9
aDP, dermal papilla; CTS, connective tissue shealth; RS, root shealth.
Table II. Inhibition of steroid sulfatase activity in various
subunits of human occipital anagen hair follicles by
different concentrations of estrone-3-O-sulfamate
Inhibitor concentration
(estrone sulfamate) Subunita Inhibition of STS activity (%)
100 mM DP 100
100 mM CTS 100
100 mM RS 100
100 nM DP 100
100 nM CTS 100
100 nM RS 100
10 mM DP 100
10 mM CTS 100
10 mM RS 100
1 nM DP 89.7
1 nM CTS 97.3
1 nM RS 80.0
aDP, dermal papilla; CTS, connective tissue shealth; RS, root shealth.
Figure 4. Steroid sulfatase immunoreactivity in human hair
follicles Immunohistochemical analysis using speci®c anti-steroid
sulfatase antibody has been performed on sections of normal human skin
as described in Materials and Methods. The steroid sulfatase immuno-
reactivity appears as a red stain. All sections were counterstained with
hemalaun. A diffuse, but strong immunoreactivity in the dermal papilla
continuing over to a much weaker staining in the connecting tissue
sheath of human terminal hair follicles in the anagen phase can be seen
in (a). In (b) a similar staining can be observed in a vellus hair. Scale bar:
60 mm.
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(Olympus, Tokyo, Japan). The dermal papilla volumes were calculated
with the ``VolumeEqSphere'' pro®le, whereas connective tissue sheath
and root sheath were calculated with the ``VolumeEqCylinder'' pro®le.
These prede®ned calculation algorithms were provided by the LUCIA
M-software. The net volume of the connective tissue sheaths was
calculated by subtraction of the corresponding root sheath volume from
the connective tissue sheaths gross volume. This way it was possible to
calculate steroid sulfatase, 17b-hydroxysteroid dehydrogenase (HSD), and
3b-HSD enzyme activities in relation to the volumes of the hair follicle
subunits.
Measurement of steroid sulfatase activity and androgen
metabolism Steroid sulfatase activity was examined in a radiochemical
assay. In preliminary experiments we ensured that there was no
breakdown of steroids when incubated in media only, and that the
inhibitor had an effect without tissues (data not shown). Single hair
follicles or six dermal papillae, three connective tissue sheaths, and three
root sheaths from one donor were pooled for one measurement. These
hair follicle subunits were incubated (37°C, 5% CO2) in a humidi®ed
atmosphere for up to 64 h in 400 ml supplemented serum-free Williams
E medium in the presence of either 5 mM DHEAS (with 2mCi
[1,2,6,7-3H]-DHEAS) alone, or in combination with various
concentrations (1 nM±100 mM) of the steroid sulfatase inhibitor estrone-
3-O-sulfamate. In addition, six dermal papillae, three connective tissue
sheaths, and three root sheaths from one donor were pooled and
incubated with either 20 nM [1,2,6,7-3H(N)]-DHEA (0.5 mCi), 15 nM
[1,2,6,7-3H(N)]-androst-4-ene-3,17-diol (androstenediol, 0.5 mCi), or
20 nM [1,2,6,7-3H(N)]-androst-4-ene-3,17-dione (androstenedione,
2 mCi) for up to 69 h in supplemented serum-free Williams E medium.
As controls, steroids were incubated with Williams E medium alone.
Thereafter, culture supernatants or control incubations were extracted
twice with three volumes of chloroform/methanol 2:1. Extracts were
evaporated at 45°C and stored under nitrogen at ±70°C until analysis.
The residue was taken up in 80 ml methanol and aliquots of 20 ml were
analyzed by high-performance liquid chromatography (HPLC) with a
HP1050 chromatograph. The following systems were used: (i) a
Beckman Ultrasphere ODS column (5 mm, 4.6 3 250 mm) eluted with
acetonitrile/methanol/water 1:3:3; (ii) a Merck Purospher RP-18
column (5 mm, 4.5 3 125 mm) eluted with acetonitrile/water 3:7; ¯ow
rate was 1 ml per min. The radioactive metabolites and the remaining
substrate were quanti®ed using a Radiomatic Flow-one Beta continuous-
¯ow liquid scintillation counter (Canberra Packard, Meriden CT). Peaks
were identi®ed by their comigration with unlabeled steroids (detected by
ultraviolet absorption at 210 nm) or by comigration with 14C-labeled
Table III. Metabolic pro®le of DHEA-incubated subunits of human occipital terminal hair follicles
Conversion of DHEA to metabolitesb (% of total)
Subunita Time (h) DHEA Androstenedione Androstanedione Androsterone Androstenediol T DHT
DP 24 99.3 0.1 0.2 NDc 0.4 ND ND
DP 39 95.0 0.1 0.3 ND 0.55 ND ND
DP 48 98.4 0.1 ND ND 1.5 ND ND
DP 64 97.8 0.2 ND ND 2.0 ND ND
CTS 24 91.9 1.0 2.1 ND 5.0 ND ND
CTS 39 85.6 2.5 2.0 1.0 8.9 ND ND
CTS 48 95.1 1.0 ND ND 3.9 ND ND
CTS 64 94.2 0.8 ND ND 5.0 ND ND
RS 24 79.0 4.2 3.0 2.0 11.8 ND ND
RS 39 69.1 4.0 3.8 4.2 18.9 ND ND
RS 48 94.5 0.7 ND ND 4.8 ND ND
RS 64 93.2 1.0 ND ND 5.8 ND ND
aDP, dermal papilla; CTS, connective tissue shealth; RS, root shealth.
bThe experimental protocol is described in Materials and Methods.
cND, not detected.
Table IV. Metabolic pro®le of androstenediole or androstenedione-incubated subunits of human occipital terminal hair
follicles
Conversion of DHEA to metabolitesb (% of total)
Subunita Substrate Time (h) DHEA Androstenedione Androstanedione Androsterone Androstenediol T DHT
DP Androstenediol 48 2.5 ND ND ND 791 18.1 0.3
DP Androstenediol 48 1.7 ND ND ND 838 14.5 ND
DP Androstenediol 70 6.7 ND ND ND 662 26.4 0.7
DP Androstenedione 48 ND 97.2 2.5 ND ND 0.3 ND
DP Androstenedione 70 ND 94.3 5.1 ND ND 0.6 ND
CTS Androstenediol 48 8.0 ND ND ND 92.0 ND ND
CTS Androstenediol 48 6.3 ND ND ND 93.7 ND ND
CTS Androstenediol 70 9.3 ND ND ND 90.7 ND ND
CTS Androstenedione 48 ND 99.5 0.5 ND ND ND ND
CTS Androstenedione 70 ND 97.2 2.0 ND ND 0.8 ND
RS Androstenediol 48 6.4 ND ND ND 936 ND ND
RS Androstenediol 48 5.5 ND ND ND 945 ND ND
RS Androstenediol 70 9.4 ND ND ND 906 ND ND
RS Androstenedione 48 ND 99.1 0.9 ND ND ND ND
RS Androstenedione 70 ND 97.0 2.3 ND ND 0.7 ND
aDP, dermal papilla; CTS, connective tissue shealth; RS, root shealth.
bThe experimental protocol is described in Materials and Methods.
cND, not detected.
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steroids. The steroid sulfatase activities were calculated from the relative
amounts of DHEA and were normalized to the calculated volume of
each subunit.
Skin biopsies Pieces of human skin were removed in the process of
elective plastic surgery after informed consent. The skin pieces were
snap-frozen in liquid nitrogen-chilled isopentane. Frozen sections were
cut, put on to 3-(triethoxysilyl)-propylamine (Sigma, St Louis, MO)-
coated glass slides and ®xed for 10 min in acetone at room temperature.
Thereafter, the slides were kept at ±20°C for up to 8 wk until the slides
were rehydrated and stained with primary antibody.
Immunochemistry Mouse monoclonal anti-rat steroid sulfatase
(P42B2) has been described previously (Kawano et al, 1989). This
antibody was shown by immunoprecipitation to cross-react with puri®ed
human steroid sulfatase but not with human arylsulfatases A and B. The
primary antibody bound to frozen skin sections was detected using the
LSAB 2 alkaline phosphatase±anti-alkaline phosphatase staining kit
(Dako) according to the manufacturer's instructions. All sections were
counterstained with hemalaun. To control the speci®city of staining,
mouse IgG (Dako) was used at equimolar concentrations as a primary
antibody; slides not stained with primary antibody constituted an
additional negative control. The staining was evaluated under light
microscope (Olympus BX60).
RESULTS
Steroid sulfatase activity is present in complete human hair
follicles We incubated isolated hair follicles with DHEAS at
5 mM. This concentration was chosen (i) because DHEAS is found
in human plasma in the range of 0.5±10 mM, and (ii) because
steroid sulfatase will be saturated with the substrate at 5 mM
(Km = 1.7 mM). Culture supernatants collected from DHEAS
incubated with complete hair follicles were analyzed by HPLC
and revealed the formation of DHEA as a reaction product,
whereas this product was not formed in control incubations in
medium alone. The amount of DHEA formed was directly related
to the number of hair follicles used in the incubation (Fig 3).
Steroid sulfatase activity concentrates in the dermal papilla
of human beard and occipital hair follicles and is inhibited
with estrone-3-O-sulfamate We incubated the subunits of the
hair follicles with the androgen precursors DHEA, androstenediol,
and androstenedione. Concentrations of the steroids (15±20 nM)
near to the maximal serum levels encountered in normal human
serum were chosen for these experiments. Control incubations of
steroids with medium alone did not give rise to any degradation
products. Upon separate incubation of dermal papillae, connective
tissue sheaths and root sheaths with DHEAS, DHEA was formed in
each case as the only detectable reaction product. We calculated the
speci®c activity of steroid sulfatase according to the volumes of
different hair follicle subunits (Table I) and found that the activity
was signi®cantly higher (p < 0.01) in the dermal papilla by a factor
of 6±8 as compared with the steroid sulfatase activity in the
connective tissue sheaths or root sheaths. In beard dermal papillae
we also observed an augmented STS activity as compared with the
steroid sulfatase activity in the connective tissue sheaths or root
sheaths (Table I). When estrone-3-O-sulfamate was added to
incubations of hair follicles subunits with DHEAS, we observed
complete inhibition of DHEA formation at 100 mM, 100 nM, and
10 nM, and still 89 6 8% of inhibition at 1 nM (mean of three
experiments) (Table II).
Steroid sulfatase immunostaining is predominantly
observed in the dermal papillae of human hair follicles In
human skin, steroid sulfatase immunoreactivity was almost
exclusively found in the hair follicles. As shown (Fig 4), the cells
comprising dermal papillae display strong steroid sulfatase
immunoreactivity (Fig 4A). This was also true for the dermal
papillae in vellus hair follicles (Fig 4B). The sections stained with
control antibody and secondary antibody revealed no
immunoreactive signals in normal skin (data not shown).
The dermal papilla of occipital hair follicles is able to
metabolize DHEA(S) to 5a-DHT We incubated the subunits
of the hair follicle with the androgen precursors DHEA,
androstenediol, and androstenedione. Concentrations of the
steroids (15±20 nM) near to the maximal serum levels
encountered in normal human serum were chosen for these
experiments. Control incubations of steroids with medium alone
did not give any degradation products. Upon separate incubation of
dermal papillae, connective tissue sheaths, and root sheaths with
DHEA, androstenediol and androstenedione were formed as
detectable reaction products. Interestingly, there was a marked
preponderance of androstenediol synthesis indicating higher 17b-
HSD enzyme activities as compared with 3b-HSD when DHEA
was used as a substrate (Table III). Subsequently, androstenedione
Table V. Enzyme activity of 3b-HSD in subunits of the human terminal hair follicle
Subunitsa
3B-HSD activity (pmol per h per mm3)
Androstenediol DHEA
Exp. 1 (48 h) Exp. 2 (70 h) Exp. 2 (48 h) Exp. 3 (24 h) Exp. 3 (39 h) Exp. 4 (48 h) Exp. 4 (64 h)
DP 12.72 18.6 4.39 0.048 0.132 0.011 0.017
CTS 0 0 0 0.034 0.040 0.011 0.011
RS 0 0 0 0.025 0.055 0.003 0.017
aDP, dermal papilla; CTS, connective tissue shealth; RS, root shealth.
Figure 5. 5a-DHT is the ultimate reaction product after
incubation of dermal papillae with androstenediol. Six dermal
papillae were microdissected as described in Materials and Methods and
incubated in the presence of 15 nM androstenediol (2 mCi [1,2,6,7-3H]-
androstenediol) in a total volume of 400 ml. Culture supernatants were
analyzed by HPLC and revealed the formation of 5a-DHT as the
ultimate product, indicating 3b-HSD and 5aR activity. The elution time
of potential reaction products that were not observed (1:
androstenedione; 2: androstanedione; 3: androsterone) is indicated by
arrows.
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and androstenediol were used as substrates upon separate
incubations of dermal papillae, connective tissue sheaths, and root
sheaths: androstenedione was only slightly metabolized (mainly to
androstenedione), whereas androstenediol was highly metabolized
(Table IV). In contrast to root sheaths and connective tissue
sheaths where androstenediol was metabolized via 17b-HSD to
DHEA, the dermal papilla revealed an intense 3b-HSD activity
resulting in testosterone as an intermediate reaction product and 5a-
DHT as the ®nal metabolite (Fig 5). We calculated the speci®c
activity of 3b-HSD according to the volumes of different subunits
and the different substrates used, and found that the activity of the
3b-HSD was exclusively expressed within the dermal papilla upon
incubation with androstenediol (Table V).
The dermal papilla of beard hair follicles is able to
metabolize DHEA(S) to 5a-DHT We incubated the
subunits of the hair follicle from with the androgen precursors
DHEA(S) and androstenediol. Control incubations of steroids with
medium alone did not give any degradation products. Upon
separate incubation of dermal papillae, connective tissue sheaths and
root sheaths with DHEA(S), DHEA was formed, thus proving the
concept that STS is also present in androgen-dependent hair
follicles. Interestingly, incubation with androstenediole resulted in
the detection of 5a-DHT when beard dermal papillae were used as
tissues (Table VI).
DISCUSSION
Elevated DHEAS plasma levels have been seen in young men with
early onset AGA (Pitts, 1987). Whereas this phenomenon may be
con®ned to patients with adrenal hyperactivity, even in the
presence of normal DHEAS levels, increased utilization of this
precursor might lead to a pathogenic effect within susceptible hair
follicles. In fact, activities of both 3b-HSD (Sawaya et al, 1988;
Sawaya, 1991) and of 17b-HSD (Sawaya, 1991) are elevated in
sebaceous glands isolated from balding frontal areas of the male
scalp as compared with those isolated from nonbalding occipital
areas. In women showing androgen-dependent female-pattern
alopecia, both signi®cantly higher DHEAS serum levels and highly
ef®cient conversion of DHEA to androstenediol by the hair follicles
as compared with total skin was noted, suggesting a higher rate of
conversion to active androgens. Finally, elevated DHEAS is a major
hormonal change in hirsutism (Haning, 1981). Utilization of
DHEA and active androgen production by the skin was found to be
signi®cantly greater in hirsute women (Thomas and Oake, 1974).
According to present knowledge, DHEAS does not affect
androgen sensitive hair follicles, but conversion of DHEAS to more
potent steroids is crucial. This metabolic step is performed by
steroid sulfatase leading to DHEA. Steroid sulfatase activity is
known to be present in human skin and to be associated with both
keratinocytes and ®broblasts (Kubilus et al, 1979). In this study we
describe for the ®rst time that the dermal papilla appears to be a
major site of steroid sulfatase expression within the human hair
follicle, as evidenced by staining with a monoclonal antibody and
by direct measurement of steroid sulfatase enzyme activity. Other
parts of the hair follicle such as the connective tissue sheaths or root
sheath expressed signi®cantly lower steroid sulfatase enzyme
activity. This intrafollicular distribution might explain why one
previous study with plucked hair follicles (which will mostly lack
the dermal papilla) failed to detect steroid sulfatase activity (Fazekas
and Sandor, 1973). In addition, the substrate concentration used in
that study (1.3 nM) was suboptimal, namely far below the Km of
steroid sulfatase for DHEAS (1.7 mM (Ballabio and Shapiro, 1995).
Remarkably, the dermal papilla is the part of the hair follicle where
type 2 steroid 5aR activity is concentrated (Hoffmann and Happle,
1999) and where androgen receptors are found (Randall et al,
1993). Furthermore, it is noteworthy that the dermal papilla appears
to be the site of intense 3b-HSD enzyme activity, converting
androstenediol to the far more potent androgen testosterone. It is,
therefore, conceivable that adrenal DHEAS can be utilized by the
dermal papilla to metabolize 5a-DHT as a ligand to the androgen
receptors within the dermal papilla or its immediate vicinity. These
data suggest that DHEAS contributes to androgenic modulation of
hair growth.
Furthermore, we have demonstrated that a potent steroid
sulfatase inhibitor can ef®ciently block the activity of the enzyme
in the isolated subunits of the hair follicle, even at concentrations as
low as 1 nM. Such inhibitors could be used for intervention with
the local activation of DHEAS in the skin, and may be useful in the
treatment of AGA or hirsutism.
In summary, according to the literature DHEAS may play a part
in the pathogenesis of AGA and our results show that the metabolic
activity of steroid sulfatase within androgen-dependent (beard) and
insensitive (occiput) hair follicle results in DHEA within the dermal
papilla, which can be further metabolized to 5a-DHT. Assuming
that these mechanisms also occur in hair follicles affected by AGA,
steroid sulfatase is therefore a potential new target for pharmaco-
logic intervention to prevent or reverse AGA. Potent steroid
sulfatase inhibitors are promising candidates for a new therapeutic
approach to treat AGA.
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Table VI. Metabolic pro®le of DHEAS, DHEA, and androstenediol-incubated subunits of human beard terminal hair
follicles
Conversion of DHEAS and androstenediol to metabolitesb (% of total)
Subunitsa Substrate Time (h) DHEA Androstenediol DHT
DP
DP
DHEAS
Androstenediol
48
48
4.32
4.03
ND
91.44
9.89
1.39
CTS DHEAS 48 11.66 ND 9.05
CTS Androstenediol 48 8.50 83.31 1.4
RS DHEAS 48 17.10 ND 8.41
RS Androstenediol 48 29.79 57.94 0.60
aDP, dermal papilla; CTS, connective tissue shealth; RS, root shealth.
bThe experimental protocol is described in Materials and Methods.
cND, not detected.
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